In contrast, it is quite possible that patients may not have been completely adherent to therapy between ... Becker SL, Luber AD. Therapeutic Drug Monitoring for Antiretrovirals: Uses and Misuses ...

In this study, pharmacogenomics and therapeutic drug monitoring were used to evaluate the clinical effectiveness of genotyping chronic pain patients on analgesic therapy. It was hypothesized that ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Treatment decisions need to be based ... are changing rapidly at this time. Optimizing therapeutic strategies for cancer patients who are over 65 years of age remains a challenge.

Due to their potential to accumulate in tumors, these nanoparticles have emerged as promising drug carriers for cancer therapy and targeted ... treatments with precise monitoring of drug distribution.

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Imagine if doctors could see exactly where cancer medicine goes inside your body, how long it stays, and whether it reaches the tumor effectively. This could help make treatments safer and more ...

Polaris Pharmaceuticals is evaluating its lead therapeutic ... cancer therapy that depletes circulating arginine—in combination with standard chemotherapies and immuno-oncology drugs in various ...

It is one of the most aggressive forms of skin cancer, with current therapies—including immunotherapy and targeted ...

Targeted alpha therapy (TAT) using astatine-211 (211 At)-labeled peptides shows promise in treating metastatic melanoma, a highly aggressive skin cancer. The therapy targets melanocortin-1 ...